mRNA Vaccines and Therapeutics Market Trends 2022 | Segmentation, Outlook, Industry Report to 2028

The mRNA Vaccines and Therapeutics Market size is expected to grow at an annual average of 12% during 2021-2027. Messenger ribonucleic acid (mRNA) refers to a single protein-coding gene in the genome that serves as the basis for protein synthesis within the cell. mRNA vaccines and therapeutics combine desirable immunological properties and are manufactured in the laboratory using mammalian cells. Common types of vaccines and therapeutics include self-amplifying, non-replicating, self-replicating in vivo and non-dendritic cell non-replicating mRNA in vitro. They are injected into the body to trigger virus-sensing immune sensors and produce viral antigen proteins within the cells. This helps boost the body’s immunity by improving B-cell and T-cell responses.

The following segmentation are covered in this report:

By Application

• Cancer
• Infectious Disease
• Gene Editing
• Protein Replacement

By Treatment Type

• Bioengineered Vaccine
• Gene Therapy 
• Gene Transcription 
• Cell Therapy
• Monoclonal Antibody
• Others

By Vaccine Manufacturing

• In-House
• Out-Sourced

Company Profile

• Arcturus Therapeutics Holdings Inc.
• BioNTech SE
• CureVac N.V.
• Daiichi Sankyo Company, Limited.
• Ethris GmbH
• GlaxoSmithKline plc
• Gennova Biopharmaceuticals Ltd
• Moderna, Inc.
• Pantherna Therapeutics GmbH

Scope of the report

The research study analyses the MRNA Vaccines and Therapeutics Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by mRNA Vaccines and Therapeutics Market Report

• What was the MRNA Vaccines and Therapeutics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the mRNA Vaccines and Therapeutics Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.